China Intelligence Global (06819.HK) announced that its joint venture, Beijing Renzheng Medical Ethics, has signed a cooperation agreement with Dayuhara. The two sides will provide digital home monitoring solutions for patients on the basis of Renzheng Medical Ethics's own medical institution compliance management service cloud platform and chronic disease management service cloud platform, as well as the original registered patients of nearly 20,000 doctors. and on this basis to develop a digital remote health management scheme for rare patients.
In addition, through the domestic and overseas medical resources of the Renzheng Medical Ethics platform, CIIC Global can provide online consultation, drug consultation and process consultation for patients with rare diseases such as Duchenne muscular dystrophy and muscular dystrophy. Emergency management and other medical services. The two sides will continue to explore and deepen cooperation and carry out research projects on the treatment of rare diseases, rehabilitation and the treatment of complications for selected rare diseases.
Through this cooperation, the patients with rare diseases in Dazhiyuan can get the medical diagnosis and treatment service of Renzheng Medical Ethics through the "member emergency medical service" provided by Renzheng Medical Ethics. The two sides plan to achieve the goal of 2000 paying members of Renzheng Medical Ethics Care platform in the coming year, and the two sides are expected to accumulate a total of 20000 paying members within three years through the introduction of global medical resources and the development of full-cycle services for patients with rare diseases.